Current Cancer Drug Targets
Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets , Volume 20 - Number 2
Biography
Review Article
Nordihydroguaiaretic Acid in Therapeutics: Beneficial to Toxicity Profiles and the Search for its Analogs
, 20(2): 86 - 103Geraldine Sandana Mala John, Satoru Takeuchi, Ganesh Venkatraman* and Suresh Kumar Rayala*
DOI: 10.2174/1568009619666191022141547
Review Article
Anti-tumor Activity of Propofol: A Focus on MicroRNAs
, 20(2): 104 - 114Milad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh and Saeed Samarghandian*
DOI: 10.2174/1568009619666191023100046
Review Article
Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide
, 20(2): 115 - 129Md Wahiduzzaman, Akinobu Ota* and Yoshitaka Hosokawa
DOI: 10.2174/1568009619666191021122006
Review Article
Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization
, 20(2): 130 - 145Keywan Mortezaee, Masoud Najafi*, Bagher Farhood*, Amirhossein Ahmadi*, Dheyauldeen Shabeeb and Ahmed E. Musa
DOI: 10.2174/1568009619666191019143539
Research Article
Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter
, 20(2): 146 - 155Marc Lehmacher*, Antje Stolzenburg and Samuel Samnick
DOI: 10.2174/1568009619666191016145602
Research Article
CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling
, 20(2): 156 - 165Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
Center for Drug Discovery
University of Houston
Houston, TX
Biography
Biography of Ruiwen Zhang
Ruiwen Zhang is the Robert L. Boblitt Endowed Professor in Drug Discovery and Director of the Drug Discovery Institute at the University of Houston. With over 30 years of experience in the field of biomedical research, particularly in the area of clinical pharmacology and therapeutics, pharmaceutical and toxicological research, Dr. Zhang’s research has been continuously funded by NIH and DoD, and other agencies. He has published more than 230 papers, 2 books, and more than 50 invited reviews/book chapters as well as more than 180 meeting abstracts. For his outstanding contributions in pharmaceutical sciences, Dr. Zhang was elected as a Fellow of American Association for the Advancement of Science (AAAS) in 2009. Dr. Zhang is recently elected as Fellow of National Academy of Inventors (2018).
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Webmaster Contact: info@benthamscience.net